IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. — Form D/A
IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-07-21. $26.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-07-21
- Form: D/A
- Accession: 0002071562-26-000003
- Industry: Pooled Investment Fund
- Exemptions: 06c,3C,3C.7
- Amount sold: $26.4M
- Investors: 11
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-551618
Issuer
- Name: IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P.
- CIK: 0002071562
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: C/O COMPLIANCE DEPARTMENT 60 EAST 42ND STREET, 24TH FLOOR, NEW YORK, NY, 10165
- Phone: 2129947400
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Lauren Unger | Related Person | New York, NY |
| Michael Stanton | Executive Officer | New York, NY |
| - iCapital PE GP, LLC | Promoter | New York, NY |
Other filings by this issuer (1)
More